Matrix metalloprotease inhibitors
US6037472A · kind A · utility
12Cited by
16References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 22, 1994 |
| Grant date | Mar 14, 2000 |
| Priority date | — |
| Expiry date | Nov 22, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/18
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds of formula (I) ##STR1## and their pharmaceutically acceptable salts inhibit matrix metalloproteases, such as stromelysin, gelatinase, matrilysin and collagenase, and are useful in the treatment of mammals having disease-states alleviated by the inhibition of such matrix metalloproteases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.